2020
DOI: 10.1007/s11916-020-00902-7
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Cluster Headache Update and East–West Comparisons: Focusing on Clinical Features, Pathophysiology, and Management

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 92 publications
1
4
1
Order By: Relevance
“…Nonetheless, male predominance remains stronger in China than North America and Europe (17,18), possibly due to ethnic and genetic differences responsible for a more pronounced male predominance in China than in North America and Europe. Furthermore, some studies have reported that the proportion of cCH in Eastern countries varied between 0–7.5% (12), and our study found that only 2.33% of patients were diagnosed with cCH, which is lower than the proportion reported in North America and Europe (15,19). This prominent difference could be attributed to ethnic or cultural differences, and the larger sample in our study makes the results more reliable.…”
Section: Discussioncontrasting
confidence: 78%
“…Nonetheless, male predominance remains stronger in China than North America and Europe (17,18), possibly due to ethnic and genetic differences responsible for a more pronounced male predominance in China than in North America and Europe. Furthermore, some studies have reported that the proportion of cCH in Eastern countries varied between 0–7.5% (12), and our study found that only 2.33% of patients were diagnosed with cCH, which is lower than the proportion reported in North America and Europe (15,19). This prominent difference could be attributed to ethnic or cultural differences, and the larger sample in our study makes the results more reliable.…”
Section: Discussioncontrasting
confidence: 78%
“…In our hospital based cohort, the mean age at onset was 28.6 years, similar to the previous studies and maleto-female ratio was 5.3:1. The gender ratio was more compatible with Asian studies (5.1:1) compared to recent European/North American studies (2-3.1:1) [10,18,19,[21][22][23][25][26][27]. Research about the mean time from CH onset to correct diagnosis reported various times in different countries (in the UK: 2.6 years, in Flanders: 3.6 years, in Spain: 4.9 years, in Italy and East European countries: 5.3 6.4 years, in Denmark: 6.2-9 years, in the USA: 6.6-8.5 years, in Japan: 7.3 6.9 years) [20,[28][29][30][31][32][33][34][35].…”
Section: Demographicssupporting
confidence: 57%
“…Previous studies have shown the male to female ratio for CH ranged from 3.8-7:1 in Eastern populations, while between1.3-3.5:1 in Western populations [10]. By comparison, the male to female ratio for migraine was approximately 1:2-3 [9,11],while that for MO was further reduced to 1:2.2-1:4.9 [12][13][14][15].…”
Section: Differences In Gendermentioning
confidence: 76%